Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Oracle Investment Management
AddedFeb 15, 2024
UpdatedJun 28, 2026
Oracle Investment Management

Oracle Investment Management

Operating

OIM: A leading global healthcare investment management firm, leveraging innovation and regulation changes.

Location
Greenwich, CT, US
Founded
1993
Firm
Compare
Portfolio
Employees
Website

Oracle Investment Management (OIM) is a fundamental research-driven investment management company exclusively focused on the global healthcare and bioscience industries. Founded by Larry N. Feinberg in 1993, the firm specializes in identifying opportunities within the rapidly changing healthcare sector, driven by innovation and regulatory shifts. OIM's typical investments span various stages, including seed, Series B, and post-IPO equity rounds.

Notable portfolio companies include Aspira Women's Health, Biolase, Concentric Analgesics, and Soleno Therapeutics. With over 30 years of experience in healthcare investing, Larry Feinberg leads OIM's investment strategy, leveraging his expertise to navigate the complex and evolving healthcare landscape. The firm's focused approach and deep industry knowledge position it as a valuable partner for healthcare and bioscience startups seeking strategic investment and guidance.

Oracle Investment Management - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments9
Current Portfolio Count7
Total Portfolio Exits0

Top Investment Stages

Post Ipo Equity6 (66.7%)
Series B2 (22.2%)
Seed1 (11.1%)

Stage Mix

Post Ipo Equity 67%Series B 22%Seed 11%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Pyramid Biosciences logo

Pyramid Biosciences

Concentric Analgesics logo

Concentric Analgesics

Soleno Therapeutics logo

Soleno Therapeutics

Aspira Women's Health logo

Aspira Women's Health

Yield10 Bioscience logo

Yield10 Bioscience

Biolase logo

Biolase

Mend logo

Mend

Oracle Investment Management - Similar Investment Firms

OrbiMed Advisors logo

OrbiMed Advisors

orbimed.com

Partner Fund Management logo

Partner Fund Management

Orion Resource Partners logo

Orion Resource Partners

Orion Healthcare Equity Partners logo

Orion Healthcare Equity Partners

orhep.com

ORI Capital logo

ORI Capital

ori-capital.com

Petrichor Healthcare Capital Management logo

Petrichor Healthcare Capital Management

petrichorcap.com

PFM Health Sciences logo

PFM Health Sciences

Oak Investment Partners logo

Oak Investment Partners

oakvc.com

Omega Funds logo

Omega Funds

Sio Capital Management logo

Sio Capital Management

siocapital.com

Pimco logo

Pimco

pimco.com

Orix Growth Capital logo

Orix Growth Capital

orix.com

Oak HC/FT logo

Oak HC/FT

oakhcft.com

Oakwood Medical Management logo

Oakwood Medical Management

Orillion logo

Orillion

orillion.co

Oracle Investment Management - Classification

Also Known As
  • Oracle Investment Management, Inc.
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
Show 2 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
SIC
  • 6000Depository Institutions